Dr. P. Uma Devi joined as an Assistant Professor in the Department of Pharmacology at Amrita in May 2012. She has completed her B. Pharm., M. Pharm. and doctoral degree from Jamia Hamdard University, New Delhi. She worked in Ranbaxy Laboratories Limited for 3.5 years prior to joining Amrita. There she was involved in preparing clinical study protocols, clinical study reports, case report forms, investigator’s brochure etc. Her key areas of interest include clinical research. Currently, she is involved in drug utilization studies and is presently supervising Pharm. D. (PB) students in their research project on antidiabetic drugs.


Publication Type: Journal Article
Year of Publication Publication Type Title
2015 Journal Article Aa Unni, Jayaprakash, A. Ka, Yadukrishnan, M. Cb, and P.c Uma Devi, “Drug utilization pattern in chronic obstructive pulmonary disease inpatients at a tertiary care hospital”, International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, pp. 389-391, 2015.[Abstract]

Objective: Drug utilization studies provide useful insights into the current prescribing practices. In view of this, the present study was designed to establish the drug utilization pattern in hospitalized chronic obstructive pulmonary disease (COPD) patients. Methods: In this retrospective study, all patient data relevant to the study were obtained by examination of patient’s medical records and hospital information system. Results: A total of 237 patients with acute exacerbation were evaluated. The population predominantly consisted of males (92.4%) and most of the patients were in the age group of 61 to 70 y (39.7%). Cough, sputum production and dyspnea were observed in 88.2%, 80.6% and 37.6% patients, respectively. Hypertension (49.4%) was the most common co-morbidity. Candida albicans (16%) and Pseudomonas aeruginosa (4.6%) were the most common microorganisms isolated from sputum samples. Majority of the patients were on multidrug therapy during both hospital stay (98.7%) and at the time of discharge (99.6%). During hospital stay, the most commonly prescribed drugs were ipratropium (91.6%) and levosalbutamol (88.2%); antibiotics and systemic corticosteroids were received by 96.2% and 83.1% patients, respectively. At discharge, antibiotics, inhaled corticosteroids, methyl xanthines, long acting beta-2 agonist and tiotropium were received by 94.1%, 93.7%, 92.4%, 86.1% and 56.5% patients, respectively. Conclusion: The prescribing trend observed at our hospital appears to be in concordance with the current guidelines for the management of COPD patients. © 2014 All Rights Reserved.

More »»
Faculty Details



Faculty Research Interest:

Faculty Email: